Agonists and Antagonists
Chemical Antagonist
Interact directly with the drug/agonist - Remove the drug from the system -Prevent the drug from binding to its receptor
Emax
Maximal effect of the drug This is an indicator of efficacy
Affinity
Measure of the ability of the drug to bind its receptor site Drugs with a higher affinity are usually more potent. The smaller the Kd, the greater the affinity
noncompetitive and irreversible antagonists
Reduce Emax by reducing available receptors
Inverse Agonist vs. Antagonist
-Increasing concentrations of inverse agonist alone produces an effect. -Increasing concentrations of antagonist produces an effect only in the presence of an agonist.
Graded dose-response curve
A graph of increasing response to increasing drug concentration or dose
Quantal dose-response curve
A graph of the fraction of a population that shows a specified response at progressively increasing doses
Agonist
Any drug/chemical molecule that binds a receptor and produces an effect -The magnitude of the drug effect is proportional to the amount of drug:receptor complexes formed.
Antagonist
Any drug/chemical molecule that blocks the effect of an agonist
Describe the effect of adding a competitive antagonist to an agonist
Competitive antagonist shifts the agonist dose-response curve to the right, increasing EC50 (agonist appears less potent)
Potency
Indication of the amount of drug needed to produce a given effect Defined by the EC50 of the drug The smaller the EC50, the greater the potency
EC50
Drug dose or concentration that produces 50% of the maximal effect
3 types of agonists
Full agonists Partial agonists Inverse agonists
Allosteric modulators
Have no direct activity on their own Alter the affinity of the agonist for the receptor or the level of receptor activation after agonist binding
Describe the effect of partial agonists in the presence of agonists
They act like antagonists, reducing the Emax (efficacy) of the agonist by reducing the number of available receptors
allosteric inhibitor/antagonist
Two modes of action 1. prevents binding (lowers affinity) 2. Abolishes activation of the receptor even after the agonist is bound
Kd
drug concentration required to bind 50% of the receptor sites in the system
Physiological Antagonist
when ligands bind to two separate receptors, they produce opposing physiological effects